Comparing Antibiotic Duration of Therapy
Conditions
Brief summary
To compare and contrast antibiotic use and its effects on patient outcomes before and after the implementation of a PCT protocol in the ICU at Methodist Richardson Medical Center (MRMC).
Detailed description
Based on previous clinical trials, current literature supports the use of PCT levels in combination with clinical assessments to help determine optimal antibiotic therapy. On May 30, 2022, MRMC launched a PCT protocol in the ICU that allows clinical pharmacy specialists to order PCT levels in certain bacterial infections. In order to determine the effects of the protocol, a retrospective quasi-experimental review will be conducted
Interventions
OTHERcompare antibiotic duration of therapy
To compare antibiotic duration of therapy before and after the implementation of the PCT protocol in the ICU.
Sponsors
Methodist Health System
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
Yes
Inclusion criteria
* ● Patients aged 18 years or older * Patients being monitored on the PCT protocol * ICU location status for at least part of the admission * Received antibiotics in the ICU for a diagnosis of: * Community-acquired pneumonia * Hospital-acquired pneumonia * Ventilator-associated pneumonia * Sepsis and/or septic shock * Uncomplicated bacteremia with known source * Chronic obstructive pulmonary disorder exacerbation * Asthma exacerbation
Exclusion criteria
* Received antibiotics in the ICU for a diagnosis of: * Uncomplicated skin and soft tissue infections * Abscess * Empyema * Bacterial infections that require prolonged antibiotic therapy (e.g., osteomyelitis, endocarditis, tuberculosis, etc.) * Intra-abdominal infection * Urinary tract infection * Bacterial meningitis * Estimated Glomerular Filtration Rate \<15 mL/min * Requiring renal replacement therapy * Status post cardiac arrest/target temperature management
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Total days of antibiotic therapy | 6 months | Actual antibiotic days and predicted antibiotic days (i.e., SAAR) |
Countries
United States
Outcome results
None listed